Dimas Alexandre Kliemann

A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial

Sunil S. Solomon, Sandra Wagner-Cardoso, Laura Smeaton et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 108 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Prevention of HIV-1 Infection with Early Antiretroviral Therapy for the HPTN 052 Study Team*

Myron S. Cohen, Ying Qing Chen, Marybeth McCauley et al. · 2011 · 86 citations

Public Health, Infectious Diseases, Preventive Medicine +16

Candida esophagitis: species distribution and risk factors for infection

Dimas Alexandre Kliemann, Alessandro C. Pasqualotto, Maicon Falavigna et al. · Revista do Instituto de Medicina Tropical de São Paulo · 2008 · 64 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +10

Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care

Pallav L. Shah, Christopher M. Orton, Beatriz Grinsztejn et al. · The Lancet Respiratory Medicine · 2022 · 57 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

HBV Carrying Drug-Resistance Mutations in Chronically Infected Treatment-Naive Patients

Michele Soares Gomes‐Gouvêa, Ariana Carolina Ferreira, Rosângela Teixeira et al. · Antiviral Therapy · 2014 · 42 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17